Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Filoviridae Infections”

107 trials

Showing 20 of 107 results

Early research (Phase 1)Study completedNCT00072605
What this trial is testing

Experimental Ebola Vaccine Trial

Who this might be right for
Hemorrhagic Fever, EbolaHealthy
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableStudy completedNCT03140774
What this trial is testing

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Who this might be right for
Ebola Virus Disease
University of Oxford 126
Early research (Phase 1)Ended earlyNCT02041715
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 21
Early research (Phase 1)Study completedNCT02354404
What this trial is testing

Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT03719586
What this trial is testing

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 681
Large-scale testing (Phase 3)Study completedNCT03161366
What this trial is testing

Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Epicentre 500
Early research (Phase 1)Study completedNCT03428347
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

Who this might be right for
Healthy
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Early research (Phase 1)Study completedNCT02240875
What this trial is testing

Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Who this might be right for
EbolaEbola Zaire
University of Oxford 91
Large-scale testing (Phase 3)Study completedNCT02342171
What this trial is testing

Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea

Who this might be right for
Hemorrhagic Fever, Ebola
Institute of Tropical Medicine, Belgium 606
Early research (Phase 1)WithdrawnNCT02389192
What this trial is testing

Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT02368119
What this trial is testing

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Who this might be right for
Ebola Virus DiseaseHemorrhagic Fever
University of Maryland, Baltimore 60
Testing effectiveness (Phase 2)Study completedNCT03333538
What this trial is testing

Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Not applicableUnknownNCT06093646
What this trial is testing

Addressing Medium- to Long-term EBOLA Associated Psychological Distress and Psychosocial Problems in Central Uganda

Who this might be right for
Ebola Virus Disease
MRC/UVRI and LSHTM Uganda Research Unit 1,000
Early research (Phase 1)Study completedNCT01353027
What this trial is testing

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Not applicableUnknownNCT04235361
What this trial is testing

Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC

Who this might be right for
Ebola Virus DiseaseMalariaTyphoid Fever+3 more
University of Stirling 500
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Testing effectiveness (Phase 2)Study completedNCT04028349
What this trial is testing

ZEBOVAC (Ebola Vaccine Trial, Ad26.ZEBOV/MVA-BN-Filo)

Who this might be right for
Ebola Virus Disease
MRC/UVRI and LSHTM Uganda Research Unit 800
Early research (Phase 1)Ended earlyNCT01518881
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 24
Testing effectiveness (Phase 2)Study completedNCT04385719
What this trial is testing

Drug-drug Interactions Between Remdesivir and Commonly Used Antiretroviral Therapy

Who this might be right for
EbolaHIV/AIDS
Makerere University 24
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation